Skip to main content
Bernard Moss, MD, Other MD/DO, Bethesda, MD

BernardMossMDPh.D.

Other MD/DO Bethesda, MD

NIH Distinguished Investigator, Chief Laboratory of Viral Diseases

Dr. Moss is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Moss' full profile

Already have an account?

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineClass of 1961

Publications & Presentations

PubMed

Journal Articles

  • RNA Polymerase Mutations Selected During Experimental Evolution Enhance Replication of a Hybrid Vaccinia Virus with an Intermediate Transcription Factor Subunit Replac...  
    Bernard Moss, MD, mBio

Press Mentions

  • Mice Studies Illustrate Potential of Chimp/Human Antibodies to Protect Against Smallpox
    Mice Studies Illustrate Potential of Chimp/Human Antibodies to Protect Against SmallpoxFebruary 1st, 2006
  • Triplex Meets Primary Endpoint in Phase 2 Clinical Trial, Reduces Rate of Cytomegalovirus (CMV) Complications in Transplant Recipients by 50 Percent
    Triplex Meets Primary Endpoint in Phase 2 Clinical Trial, Reduces Rate of Cytomegalovirus (CMV) Complications in Transplant Recipients by 50 PercentMarch 26th, 2019
  • Novel Avian Paramyxovirus-Based Vaccine Vectors Expressing the Ebola Virus Glycoprotein Elicit Mucosal and Humoral Immune Responses in Guinea Pigs
    Novel Avian Paramyxovirus-Based Vaccine Vectors Expressing the Ebola Virus Glycoprotein Elicit Mucosal and Humoral Immune Responses in Guinea PigsApril 3rd, 2019
  • Join now to see all